Wearifi

News

LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development.

News

Sanofi has licensed rights to Kali's trispecific T-cell engager KT501, in trials for rheumatoid arthritis, in a deal valued at nearly $1.2bn.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.